Related Experiment Video
Updated: Aug 5, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
Signaling antibodies complexed with adenovirus circumvent CAR and integrin interactions and improve gene delivery
E Li1, S L Brown, D J Von Seggern
1Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Abstract:
Current adenoviral (Ad) vectors cannot be targeted to specific cell types due to the widespread distribution of the Ad receptor (CAR). Moreover, CAR and/or internalization receptors (alphav integrins) are absent or present at low levels on some cell types, rendering them resistant to Ad-mediated gene delivery. To address these problems, we have developed a novel vector targeting approach that takes advantage of the common cell signaling pathways initiated by ligation of alphav integrins and growth factor receptors. Recombinant growth factor/cytokines (TNF-alpha, IGF-1, EGF) which trigger phosphatidylinositol-3-OH kinase (PI3K) activation, a signaling molecule involved in adenovirus internalization, were fused to a monoclonal antibody specific for the viral penton base. Ad vectors complexed with these bifunctional mAbs increased gene delivery 10 to 50-fold to human melanoma cells lacking alphav integrins. The bifunctional mAbs also enhanced gene delivery by fiberless adenovirus particles which cannot bind to CAR. Improved gene delivery correlated with increased virus internalization and attachment as well as PI3K activity. The use of bifunctional mAbs to trigger specific cell signaling pathways offers a widely applicable method for bypassing the normal Ad receptors in gene delivery and potentially increasing the selectivity of gene transfer.
Insights
Researchers developed a novel gene delivery method using bifunctional antibodies to target adenoviral vectors. This approach enhances gene transfer efficiency by leveraging cell signaling pathways, overcoming limitations of current receptor-dependent methods.
Area of Science:
- Biotechnology
- Molecular Biology
- Gene Therapy
Background:
- Adenoviral (Ad) vectors are widely used for gene delivery but face limitations.
- Current Ad vectors target the coxsackie adenovirus receptor (CAR), which is broadly distributed.
- Some cell types lack CAR or other internalization receptors, hindering Ad-mediated gene delivery.
Purpose of the Study:
- To develop a novel vector targeting approach for Ad-mediated gene delivery.
- To overcome limitations of CAR-dependent targeting and improve gene delivery to resistant cell types.
- To enhance the selectivity and efficiency of gene transfer using Ad vectors.
Main Methods:
- Developed bifunctional monoclonal antibodies (mAbs) by fusing recombinant growth factors/cytokines (TNF-alpha, IGF-1, EGF) to an antibody targeting the viral penton base.
- These growth factors/cytokines trigger phosphatidylinositol-3-OH kinase (PI3K) activation, a key signaling pathway for Ad internalization.
- Complexed Ad vectors with bifunctional mAbs and tested gene delivery to human melanoma cells lacking alphav integrins and using fiberless Ad particles.
Main Results:
- Gene delivery increased 10 to 50-fold to human melanoma cells lacking alphav integrins when using Ad vectors complexed with bifunctional mAbs.
- Enhanced gene delivery was observed with fiberless adenovirus particles, which do not bind to CAR.
- Improved gene delivery correlated with increased virus internalization, attachment, and PI3K activity.
Conclusions:
- Bifunctional mAbs targeting cell signaling pathways offer a novel strategy for Ad vector targeting.
- This approach effectively bypasses normal Ad receptors (CAR and alphav integrins) for gene delivery.
- The method holds potential for widespread application in enhancing gene transfer selectivity and efficiency.
More Related Videos
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...

